Recent Developments on Ketolides and Macrolides

Author(s): Yong-Jin Wu, Wei-Guo Su

Journal Name: Current Medicinal Chemistry

Volume 8 , Issue 14 , 2001

Become EABM
Become Reviewer


Recent semi-synthetic studies of erythromycin A culminated in the discovery of two ketolide drug candidates, HMR-3647 and ABT-773, for the treatment of community-acquired bacterial infections caused by both macrolide- and β-lactam-susceptible and -resistant S. pneumoniae, gram negative bacteria, and intracellular atypical pathogens. The discovery of ketolides has rekindled interest in macrolides, and recent efforts have also led to a novel class of 4”-carbamates with activity against macrolide-resistant organisms. This review is an account of recent developments on ketolides and macrolides in terms of both chemistry and antibacterial activity.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2001
Page: [1727 - 1758]
Pages: 32
DOI: 10.2174/0929867013371671
Price: $65

Article Metrics

PDF: 1